Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP394923.RAb8f1cbgKCOSsIb0x7f3mS0UwIaP7pi0G36UIt5BeLKI130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394923.RAb8f1cbgKCOSsIb0x7f3mS0UwIaP7pi0G36UIt5BeLKI130_provenance.
• NP395421.RAS19qwvZ0nLEdQlSWCj9YO3wZ07SnHpJCgd-ACKtoyXk130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395421.RAS19qwvZ0nLEdQlSWCj9YO3wZ07SnHpJCgd-ACKtoyXk130_provenance.
• NP1026701.RAbDWP2VlnBb4XQvD0tG8T2F-te8Eh3sJq_ipAyjN6haA130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026701.RAbDWP2VlnBb4XQvD0tG8T2F-te8Eh3sJq_ipAyjN6haA130_provenance.
• NP1026703.RAYbHybv0uxGw7xyhVv_YlOXEvwQ5TIiwrSKGnIiPI2Mo130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026703.RAYbHybv0uxGw7xyhVv_YlOXEvwQ5TIiwrSKGnIiPI2Mo130_provenance.
• NP1026707.RADhJfwR_OezFM22VL5u3SFQDJc3kSkmrQ6JygCu1bASY130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026707.RADhJfwR_OezFM22VL5u3SFQDJc3kSkmrQ6JygCu1bASY130_provenance.
• NP1026698.RAuUtpshOeepiz4krkSVhHaBkcGBLogewfI-HtwWJ0KVk130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026698.RAuUtpshOeepiz4krkSVhHaBkcGBLogewfI-HtwWJ0KVk130_provenance.
• NP1026699.RAknOdwn1iF2LOlB1O8BjWCSLLiG75OmPzHVSE2lnP2UU130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026699.RAknOdwn1iF2LOlB1O8BjWCSLLiG75OmPzHVSE2lnP2UU130_provenance.
• NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026706.RApX0QA4de7FTUZCoV9b2GRGg8lOznQCnHwSn5b8wjQBM130_provenance.
• NP1026702.RAGrbUJEgxyc58Q-XuZwdRVMRCsro6abtIA8CtGZecg14130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026702.RAGrbUJEgxyc58Q-XuZwdRVMRCsro6abtIA8CtGZecg14130_provenance.
• NP1026704.RAHU9MEwX04VC0r5H3xt6EsaiKvf5XCwwJsAb6apVcojg130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026704.RAHU9MEwX04VC0r5H3xt6EsaiKvf5XCwwJsAb6apVcojg130_provenance.
• NP1026705.RAFEgZ5lNCq94bM9kdPPjN4Hy65lALUbehU4jPnKoLxAU130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026705.RAFEgZ5lNCq94bM9kdPPjN4Hy65lALUbehU4jPnKoLxAU130_provenance.
• NP1026708.RA4cdEpM8B23X2pSByEVkgyIOdNPMyDVguWodlS1y3bIg130_assertion description "[In this study, we demonstrate for the first time that 17?-estradiol (E2) and the selective GPER ligand G-1 regulate FASN expression and activity through the GPER-mediated signaling, which involved the EGF receptor/ERK/c-Fos/AP1 transduction pathway, as ascertained by using specific pharmacological inhibitors, performing gene-silencing experiments and ChIP assays in breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1026708.RA4cdEpM8B23X2pSByEVkgyIOdNPMyDVguWodlS1y3bIg130_provenance.